Content Library

Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis

Journal/Conference:

JCER

Author(s):

Imtiaz A Samjoo, Christopher Drudge, Sarah Walsh, Santosh Tiwari, Róisín Brennan, Ibolya Boer, Dieter A Häring, Luisa Klotz, Nicholas Adlard, and Judit Banhazi Publication Journal Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis

Publication Date:

2023

Topic/Therapeutic Area:

Multiple Sclerosis, Nervous System

An improved definition and SAFE Rule for Predicting Difficult Intravascular Access (DIVA) in Hospitalized Adults

Journal/Conference:

Journal of Infusion Nursing

Author(s):

Amit Bahl, Kimberly Alsbrooks, Kelly Ann Zazyczny, Steven Johnson, Klaus Hoerauf

Publication Date:

2023

Topic/Therapeutic Area:

Cardiovascular

An umbrella review of the surgical performance of Harmonic ultrasonic devices and impact on patient outcomes

Journal/Conference:

BMC Surgery

Author(s):

Robert Kloosterman, George W. J. Wright, Elizabeth M. Salvo-Halloran, Nicole C. Ferko, John Z. Mennone, Jeffrey W. Clymer, Crystal D. Ricketts, Giovanni A. Tommaselli

Publication Date:

2023

Healthcare Resource Utilization and Costs Among Overweight and Obese Users of a Digital Weight Loss Intervention Compared to Non-Users:A Retrospective Analysis.

Journal/Conference:

JMIR Mhealth Uhealth

Author(s):

Ellen Siobhan Mitchell, Alexander Fabry; Annabell Suh Ho, Christine N May, Matthew Baldwin; Paige Blanco, Kyle Smith; Andreas Michaelides, Mostafa Shokoohi; Michael West; Kim Gotera; Omnya Massad; Anna Zhou.

Publication Date:

2023

Condition:

Obesity

Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant

Journal/Conference:

Journal of Comparative Effectiveness Research

Author(s):

Law, E., and Cameronc, C.

Publication Date:

2023

Topic/Therapeutic Area:

Breast Cancer, Oncology

Representative Engagements: Patient Access Platform for Digital Medicine Device

Identifying Rare Disease HCPs with Omnichannel Targeting

Improving Adherence & Compliance Via Patient Targeting

Oncology Launch Scenario Planning

Defining the Rare Disease Patient Journey to Support Commercialization of Therapy